Invivyd (IVVD) Cash from Operations (2021 - 2025)
Invivyd (IVVD) posted Cash from Operations of 15455000.0 for Q4 2025, down 87.33% on a QoQ basis from 8250000.0 in Q3 2025, and up 58.91% year-over-year from 9725801.89 in Q4 2024.
Invivyd (IVVD) Cash from Operations (2021 - 2025) Analysis & Trends
Invivyd's Cash from Operations history runs 5 years deep, the most recent figure standing at 15455000.0 for Q4 2025.
- Quarterly Cash from Operations rose 58.91% year-over-year to 15455000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 58135000.0 (up 65.9% YoY) and the FY2025 annual result came in at 58135000.0, up 65.9% from the prior year.
- Cash from Operations was 15455000.0 for Q4 2025 at Invivyd, down from 8250000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8250000.0 in Q3 2025 and bottomed at 73212000.0 in Q4 2021.
- A 5-year average of 40325650.0 and a median of 41124500.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 148.72% — and 2025, when it surged 79.91%.
- Invivyd's Cash from Operations stood at 73212000.0 in 2021, then surged by 35.25% to 47404000.0 in 2022, then slipped by 24.97% to 59240000.0 in 2023, then soared by 36.51% to 37610000.0 in 2024, then soared by 58.91% to 15455000.0 in 2025.
- Business Quant data shows IVVD's Cash from Operations at 15455000.0 in Q4 2025, 8250000.0 in Q3 2025, and 13301000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | -15.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.46 Mn |
| Dec 31, 2025 | -15.46 Mn |
| Sep 30, 2025 | -8.25 Mn |
| Sep 30, 2025 | -8.25 Mn |
| Jun 30, 2025 | -13.30 Mn |
| Jun 30, 2025 | -13.30 Mn |
| Mar 31, 2025 | -21.13 Mn |
| Mar 31, 2025 | -21.13 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Dec 31, 2024 | -37.61 Mn |
| Sep 30, 2024 | -41.07 Mn |
| Sep 30, 2024 | -41.07 Mn |
| Jun 30, 2024 | -41.60 Mn |
| Jun 30, 2024 | -41.60 Mn |
| Mar 31, 2024 | -50.21 Mn |
| Mar 31, 2024 | -50.21 Mn |
| Dec 31, 2023 | -59.24 Mn |
| Dec 31, 2023 | -59.24 Mn |
| Sep 30, 2023 | -35.35 Mn |
| Sep 30, 2023 | -35.35 Mn |